Before starting KMD Insights, LLC in in 2016, Kathleen M. Dowd served as Senior Vice President of Marketing at Boehringer Ingelheim, which she joined in 2007. In this role, she led the teams responsible for the strategy, planning, and promotion of all Primary Care, Established and Pipeline brands, as well as Integrated Customer Engagement/Multi-channel Marketing, Managed Markets Marketing, and Cross-cultural Marketing. Her organization was engaged in developing programs and materials utilized in local, regional, and national partnerships with organized payers and providers across Respiratory, Diabetes and Cardiovascular.
Prior to serving in this role, Kathleen was the Zone Vice President of Sales for the Southeast region of the US, following her Zone Vice President role in the Central region. Kathleen started her BI career as Vice President of Respiratory Marketing. In this capacity, she doubled SPIRIVA sales to over $2B within 4 years, devised a new selling model --- Clinical Science Consultants, and launched a comprehensive COPD market development plan which included the award winning DRIVE4COPD campaign. She is recognized for implementing unique marketing and sales models that drive industry and customer collaborations.
Before joining BI, Kathleen spent over 16 years at Pfizer, Inc. that included the launch of LYRICA for neuropathic pain, epilepsy, and fibromyalgia, as well as the launches of CELEBREX and GEODON.
Kathleen holds a B.S. in Animal Science / Business Management and Marketing from Cornell University and an M.B.A. in Marketing from Fordham University.
Dan Armstrong and Keith Mattox worked together in New York City at the Globecon Group, which went out of business on 9/11.
Born in the era of US bank deregulation, the Globecon Group gave commercial loan officers the skills to advise companies on a broad range of corporate finance, capital markets and derivatives tools. Dan and Keith learned about the internet together by bringing Globecon's educational guides and diagnostics to the web in the form of Fintranet, an online training platform that we built from the ground up starting in 1998.
Dan later went to The Economist, where he wrote about finance, analytics, and risk and compliance. At Deloitte he developed cybersecurity and disease tracking dashboards for NIST and NIH. He now has his own company (https://analyzethis.net/) and focuses on Fintech, as well as writing for Forbes on AI and process automation.
Dan holds an MA from Hunter College and an MBA in Finance and Research Methods from Columbia University.